Regenerative Biologics Supplier for Orthopedic Practices in Tallahassee, FL

How orthopedic practices qualify a biologics vendor

Orthopedic practices and ambulatory surgery centers generally start a vendor review by requesting the same core documents regardless of region: a certificate of analysis for the specific lot under consideration, a donor eligibility summary, and a description of how the tissue was recovered and processed.

Many groups route this review through a credentialing or compliance committee before a product is added to an approved vendor list, particularly when a surgery center maintains its own supply formulary separate from an individual physician's office.

• Certificate of analysis and lot release records
• Donor eligibility and serology testing summary
• Processing and storage description for the specific format ordered

NPI-verified accounts

Precision Biologics opens accounts only for licensed professionals, and verification begins with the ordering provider's National Provider Identifier through the NPPES registry.

For a group practice with multiple orthopedic surgeons, we ask the practice to identify the ordering physician or medical director of record so that account privileges and order history are tied to a specific license.

Shipping and cold-chain handling for orders into the Southeast

Cryopreserved Wharton's jelly formats ship overnight on dry ice in validated containers and are tracked from release to delivery; lyophilized formats ship at ambient temperature per the product insert.

Because a surgery center's receiving window can be narrower than a standard office, we ask Tallahassee-area practices to confirm a receiving contact and delivery window before an order ships so a cryopreserved shipment is not left unattended.

Verifying licensure and medical director oversight

We ask every ordering account to confirm its state licensure status directly with the Florida Board of Medicine or Board of Osteopathic Medicine, and to consult its own counsel on how a given intended use is classified under federal tissue regulations.

Florida's SB 1768, effective July 1, 2025, allows physicians to use certain non-FDA-approved stem cell therapies under specific informed consent and disclosure conditions in orthopedics, wound care and pain management; it does not change federal FDA requirements that apply to a specific product, and practices should confirm its scope with counsel rather than rely on a supplier's summary.

Precision Biologics does not advise on clinical use, dosing or procedure selection; our role is limited to supplying documented product to verified accounts.

These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.